November 2008 - Volume 200

• Controversial report spells doom for EU pharmaceutical parallel trade industry
  
• Delayed EU pharmaceutical package launch sees industry concerned for its survival
  
• EU and US set to take regulatory relationship further
  
• EGA seeks to incite revolution in European patent system
  
• EU half-year report highlights strain of SA and paediatric workload at EMEA
  
• Increased psychiatric events prompt EMEA to urge Acomplia MA suspension
  
• The Pharmaceutical Forum: real progress or hot air?
  
• Eurobarometer poll highlights EU citizens’ concerns about animal cloning
  
• Commission issues guidelines on radiopharmaceuticals
  
• EFSA sets out its challenges and objectives for the next five years
  
• EFSA highlights need for more data on nano-applications in food 

FEATURES AND COMMENTARIES

• Who owns the patents in a joint development?
  
• Work involving human tissue samples – a new era in the UK
  
• US and EU pharmacovigilance compared: contemporary approach for spontaneous consumer report
  
• Updated medical devices registration on the way for Poland

INTERVIEW

NATIONAL NEWS

• Proposed regulation on orphan drug reimbursement ignites German pharma industry
  
• German diagnostics industry lauds revolution in self-financed tests sector
  
• Lack of knowledge on drug purchase internet risks irks Norwegian agency
  
• German pharma industry looks on enviously as Austria lowers VAT on medicines
  
• German healthcare stakeholders unite to offer balanced patient information
  
• Polish new drugs advertising ordinance is unrealistic, says pharma industry
  
• Polish competition watchdog to scrutinise country’s obligatory health insurance fund
  
• Czech Republic cuts maximum drug prices to generate CZK3bn in savings
  
• The Czech Republic increases public funds for children’s vaccination
  
• Irish healthcare body increases drugs wholesale mark-ups, following Court ruling
  
• Sweden strikes back at counterfeit drugs websites with new net, press and TV presence
  
• UK medicines agency raises fees in line with increased workload
  
• Russian pharma strategy cheers domestic firms but is criticised by state purse-keeper
  
•  Slovak Constitutional Court to rule on profit ban in obligatory health insurance system
  
• Bulgarian patients blame state policy for poor access to medicines
  
• Pharmacies worry about revenues, as drugs prices in Czech Republic continue to decrease
  
• Irish medicines body announces 2009 fee increase
  
• Denmark combats fear-mongering emails on EU food supplement legislation
  
• Poland transposes EU Braille format requirements for drug packaging
  
• Macedonia launches HPV vaccination campaign
  
• Bulgarian pharmacies inspection reveals serious infringements